Ken Griffin Homology Medicines, Inc. Transaction History

Citadel Advisors LLC

$509 Billion
Q1 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.53 - $1.14 $429,262 - $923,319	-809,929 Reduced 92.13%	69,183 $42,000
Q3 2023 Nov 14, 2023	BUY	$0.84 - $1.43 $132,729 - $225,955	158,011 Added 21.91%	879,112 $1.03 Million
Q2 2023 Aug 14, 2023	SELL	$0.83 - $1.12 $151,914 - $204,993	-183,030 Reduced 20.24%	721,101 $634,000
Q1 2023 May 15, 2023	SELL	$0.91 - $1.69 $188,751 - $350,538	-207,419 Reduced 18.66%	904,131 $931,000
Q4 2022 Feb 14, 2023	BUY	$1.09 - $2.04 $26,665 - $49,906	24,464 Added 2.25%	1,111,550 $1.4 Million

Q3 2022 Nov 14, 2022	BUY	$1.55 - $3.01 $56,852 - $110,403	36,679 Added 3.49%	1,087,086 $1.75 Million
Q2 2022 Aug 15, 2022	BUY	$1.39 - $3.12 $854,349 - $1.92 Million	614,640 Added 141.05%	1,050,407 $2.07 Million
Q1 2022 May 16, 2022	BUY	$2.6 - $4.17 $589,126 - $944,867	226,587 Added 108.32%	435,767 $1.32 Million
Q4 2021 Feb 14, 2022	BUY	$3.64 - $7.78 $641,018 - $1.37 Million	176,104 Added 532.42%	209,180 $0
Q3 2021 Nov 15, 2021	BUY	$6.01 - $8.71 $29,196 - $42,313	4,858 Added 17.22%	33,076 $260,000
Q2 2021 Aug 16, 2021	BUY	$6.02 - $9.64 $40,291 - $64,520	6,693 Added 31.09%	28,218 $0
Q1 2021 May 17, 2021	SELL	$9.17 - $14.8 $8.73 Million - $14.1 Million	-952,489 Reduced 97.79%	21,525 $203,000
Q4 2020 Feb 16, 2021	BUY	$8.92 - $13.29 $8.44 Million - $12.6 Million	946,080 Added 3386.84%	974,014 $11 Million
Q3 2020 Nov 16, 2020	SELL	$9.94 - $16.59 $40,167 - $67,040	-4,041 Reduced 12.64%	27,934 $299,000
Q2 2020 Aug 14, 2020	BUY	$12.07 - $19.34 $178,901 - $286,657	14,822 Added 86.41%	31,975 $486,000
Q1 2020 May 15, 2020	SELL	$12.5 - $22.04 $77,900 - $137,353	-6,232 Reduced 26.65%	17,153 $266,000
Q4 2019 Feb 14, 2020	SELL	$11.42 - $22.19 $8.11 Million - $15.7 Million	-709,740 Reduced 96.81%	23,385 $484,000
Q3 2019 Nov 14, 2019	BUY	$14.74 - $22.28 $10.2 Million - $15.4 Million	690,918 Added 1636.97%	733,125 $0
Q2 2019 Aug 14, 2019	BUY	$18.35 - $30.34 $479,558 - $792,905	26,134 Added 162.6%	42,207 $826,000
Q2 2018 Aug 10, 2018	SELL	$16.49 - $21.55 $150,322 - $196,449	-9,116 Reduced 36.19%	16,073 $0
Q1 2018 May 11, 2018	BUY	$18.66 - $18.7 $470,026 - $471,034	25,189 New	25,189 $471,000

Others Institutions Holding FIXX

# of Institutions

Shares Held

66.2K

Call Options Held

Put Options Held

View Full List

About Homology Medicines, Inc.

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

More about FIXX

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account